Close Menu
Home » Cytox, Cardiff University Win $1.1M Grant to Validate Alzheimer's Risk Panel

Cytox, Cardiff University Win $1.1M Grant to Validate Alzheimer's Risk Panel

Mar 08, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Cytox announced today that it and Cardiff University have been awarded an £800,000 ($1.1 million) grant from Innovate UK to test and validate the clinical utility of the British company's SNP-based risk assessment panel for Alzheimer's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Treatment So Far

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to Ash Dieback Disease

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

Nucleic Acids Research Papers on FIN-Seq, ChlamDB, BBCancer

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

Lawsuit on Not Knowing Father's Test Result

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Dec
11
Featured Webinar

Advances in Precision Oncology: Tertiary Analysis Software for Solid Tumor NGS

Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

What's Popular?

In Molecular Diagnostics

  1. Qiagen Says It Is Fielding Acquisition Offers

  2. Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

  3. Cancer Diagnostics Firm Lucence Raises $20M

  4. Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear

    Premium

  5. Exact Sciences Marker Panel Detects Early Liver Cancer With Triple Sensitivity of Current Biomarker

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.